Live Breaking News & Updates on Obseva Executive Committee

Stay updated with breaking news from Obseva executive committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical. ....

Plan Les Ouates , Franche Comtér , Catarina Edfj , Luigi Marro , Merck Serono , Ernest Loumaye , Economical Statistic Sciences , Articles Of Association , Compensation Committee , Master Of Business Administration , Swiss Exchange , University In Lyon , Obseva Executive Committee , Committee For The Fiscal Year , Voisin Life Sciences Consulting , Strategy Development , General Meeting , Chemin Des Aulx , Management Report , Statutory Financial Statements , Consolidated Financial Statements , Fiscal Year , Executive Committee , Chief Transformation Officer , Martan Market Gmbh , Chief Financial Officer ,

ObsEva SA: Annual General Meeting 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland - June 8, 2023 - ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for ....

Mecklenburg Vorpommern , Plan Les Ouates , Franche Comtér , Ernest Loumaye , Merck Serono , Stefan Klotter , Luigi Marro , Catarina Edfj , Master Of Business Administration , Compensation Committee , Economical Statistic Sciences , Articles Of Association , Strategy Development , Voisin Life Sciences Consulting , Committee For The Fiscal Year , Obseva Executive Committee , University In Lyon , Swiss Exchange , General Meeting , Chemin Des Aulx , Management Report , Statutory Financial Statements , Consolidated Financial Statements , Fiscal Year , Executive Committee , Chief Transformation Officer ,

ObsEva SA: ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - May 2, 2023 - ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's ....

Ernest Loumaye , Shauna Dillon , Will Brown , University In Lyon , Swiss Exchange , Obseva Executive Committee , Fabien De Ladonchamps , Chief Executive Officer , Interim Chief Executive Officer , Chief Financial , Executive Committee , Interim Chairman , Chief Executive , Chief Administrative Officer , Interim Chief Financial , Addex Therapeutics , Forward Looking , Release Change ,

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ernest Loumaye , Will Brown , Shauna Dillon , University In Lyon , Obseva Executive Committee , Swiss Exchange , Fabien De Ladonchamps , Chief Executive Officer , Interim Chief Executive Officer , Chief Financial , Executive Committee , Interim Chairman , Chief Executive , Chief Administrative Officer , Interim Chief Financial , Addex Therapeutics , Forward Looking ,

ObsEva SA: ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - March 13, 2023 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing ....

Dennis Riedl , Ernest Loumaye , Shauna Dillon , Annette Clancy , Obseva Executive Committee , University In Lyon , Swiss Exchange , Interim Chairman , General Meeting , Fabien De Ladonchamps , Chief Executive Officer , Executive Committee , Chief Administrative Officer , Interim Chief Financial , Addex Therapeutics , Interim Chief Executive Officer , Will Brown , Interim Board , Nasdaq Capital Market , Note Regarding Forward Looking Statements , Private Securities Litigation Reform Act , Risk Factors , Annual Report ,